2,α-Dimethyltryptamine (2,α-DMT) is a
tryptamine and a lesser-known
psychedelic drug. It is the 2,α-di
methylanalog of
DMT. Its synthesis was first reported in 1965.[1]Alexander Shulgin lists the dosage as 300-500
mg, and the duration as 7–10 hours in his book TiHKAL (Tryptamines I Have Known and Loved).[2] 2,α-DMT causes
mydriasis and
paresthesia. It also produces a calm,
drunk-like feeling. Very little data exists about the pharmacological properties, metabolism, and toxicity of 2,α-DMT.
References
^Heath-Brown B, Philpott PG (1965). "Studies in the Indole Series. Part I. Indolylalkylamines". Journal of the Chemical Society (Dec): 7165–7178.
doi:
10.1039/jr9650007165.
2,α-Dimethyltryptamine (2,α-DMT) is a
tryptamine and a lesser-known
psychedelic drug. It is the 2,α-di
methylanalog of
DMT. Its synthesis was first reported in 1965.[1]Alexander Shulgin lists the dosage as 300-500
mg, and the duration as 7–10 hours in his book TiHKAL (Tryptamines I Have Known and Loved).[2] 2,α-DMT causes
mydriasis and
paresthesia. It also produces a calm,
drunk-like feeling. Very little data exists about the pharmacological properties, metabolism, and toxicity of 2,α-DMT.
References
^Heath-Brown B, Philpott PG (1965). "Studies in the Indole Series. Part I. Indolylalkylamines". Journal of the Chemical Society (Dec): 7165–7178.
doi:
10.1039/jr9650007165.